This review in The Lancet Infectious Diseases argues that daptomycin has become essential for serious enterococcal bloodstream infection and endocarditis without regulatory approval, randomised trials or agreed breakpoints. CLSI treats E faecium as susceptible dose-dependent up to an MIC of 4 mg/L at 8–12 mg/kg per day, and E faecalis as susceptible up to 2 mg/L at 6 mg/kg. EUCAST sets no breakpoint at all.
The authors argue this mismatch leads to underdosing. Observational data link 10–12 mg/kg per day with lower mortality in vancomycin-resistant E faecium, though even these doses may miss pharmacodynamic targets because MIC testing is unreliable. Creatine kinase rises modestly with dose, with marked rises clearer at the highest doses.
Their pragmatic framework: at least 8 mg/kg per day for E faecium, 10–12 mg/kg for vancomycin-resistant infection, dose informed by MIC, a beta-lactam partner in endocarditis, and weekly creatine kinase. This is expert synthesis built on observational data, not a trial, and local guidance may differ — but it reflects how many ID physicians already dose.
- Consider at least 8 mg/kg per day of daptomycin for E faecium bacteraemia, and 10–12 mg/kg for vancomycin-resistant strains
- Ask the laboratory for a daptomycin MIC and interpret it alongside the dose
- Discuss adding a beta-lactam partner for enterococcal endocarditis with the ID team
- Check creatine kinase weekly and stop statins where possible during high-dose therapy
- Dose on actual body weight in most patients and adjust the interval in kidney impairment
Why it matters
Standard 6 mg/kg dosing may be too low for E faecium, and the breakpoints will not warn you.
Don't overread it
The dosing framework rests on observational data and expert opinion; no randomised trial has tested it.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free